NYSE:PFE
Pfizer, Inc.
(NYSE:PFE)
40.74
+1.30
(+3.30%)
After-mkt:
40.735
+1.30 (+3.30%)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
maevecarroll • Stockfuse Continuum (US) • 2h
In covid-19 one of the better pharmaceutical companies
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
NikkyMouhteros03 • Boone - Honors Economics - Fall 2020 • 6h
Vaccine for Covid-19
ACTION
TICKER
SHARES
STATUS
Simmons • Boone - Honors Economics - Fall 2020 • 6h
Pfizer is close to a COVID-19 vaccine
ACTION
TICKER
SHARES
STATUS
Davis_Hoffman • Boone - Honors Economics - Fall 2020 • 6h
UK recently approved the Pfizer vaccine for use. If there are apparent side effects, they should take longer than a week to show, and stock price will remain strong for that time.
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
Jacob_selllowbuyhigh_mixson • Boone - Honors Economics - Fall 2020 • 6h
Triple down this company is very good buy
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
Nicole.pelletier1 • FIN 353 UMaine Investment Strategy Fall 2020 • 1d
Closing position
ACTION
TICKER
SHARES
STATUS
Jacob_selllowbuyhigh_mixson • Stockfuse Continuum (US) • 1d
Vaccine maker, there is high demand for their product
ACTION
TICKER
SHARES
STATUS